175137-56-1 Usage
General Description
2-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethanohydrazide is a chemical compound with the molecular formula C8H12BrN5O. It is a hydrazide derivative with a pyrazole ring, and is commonly used in pharmaceutical research and drug development as a potential inhibitor or ligand for various biological targets. 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHANOHYDRAZIDE has the potential to be used in the treatment of various diseases and disorders due to its ability to interact with specific molecular targets. It is important to handle this compound with care and follow proper safety protocols due to its potential hazards and toxicity.
Check Digit Verification of cas no
The CAS Registry Mumber 175137-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,1,3 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 175137-56:
(8*1)+(7*7)+(6*5)+(5*1)+(4*3)+(3*7)+(2*5)+(1*6)=141
141 % 10 = 1
So 175137-56-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H11BrN4O/c1-4-7(8)5(2)12(11-4)3-6(13)10-9/h3,9H2,1-2H3,(H,10,13)
175137-56-1Relevant articles and documents
NOVEL HETEROARYL COMPOUND, ENANTIOMER, DIASTEREOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND ANTIVIRAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
-
Paragraph 0761; 0762; 0765; 0766, (2020/02/14)
The present invention relates to a novel heteroaryl compound, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof, and an antiviral composition comprising the same as an active ingredient. The novel compounds represented by formula (I) or formula (II) according to the present invention are remarkably superior in antiviral activity against an influenza virus, and furthermore, have low cytotoxicity and thus low adverse effects on a human body. Therefore, a pharmaceutical composition containing the same as an active ingredient can be effectively used for the prevention or treatment of diseases caused by an influenza virus infection.
